DermaGide

Device Geistlich Pharma, North America, Inc.
Total Payments
$749,359
Transactions
40
Doctors
29
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2021 $27,083 38 28
2019 $722,276 2 2

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $714,776 1 95.4%
Consulting Fee $31,050 3 4.1%
Food and Beverage $2,985 34 0.4%
Royalty or License $548.00 2 0.1%

Payments by Type

Research
$714,776
1 transactions
General
$34,583
39 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Retrospective Chart Review of Geistlich Derma Gide Wound Matrix in the Treatment of Diabetic Foot Ulcers Geistlich Pharma, North America, Inc. $714,776 1

Top Doctors Receiving Payments for DermaGide

Doctor Specialty Location Total Records
, DPM Foot & Ankle Surgery Roanoke, VA $714,817 2
, DPM Foot & Ankle Surgery Charleston, SC $15,134 2
, MD Surgery Erie, PA $8,550 1
, D.P.M Foot & Ankle Surgery Washington, DC $7,500 1
, D.P.M Podiatrist Cumming, GA $490.78 8
, D.P.M Foot & Ankle Surgery Kingstree, SC $380.10 3
Paul Glat Bala Cynwyd, PA $274.00 1
Jarrod Kaufman Brick, NJ $274.00 1
, DPM Podiatrist Boston, MA $132.22 1
, DPM Foot & Ankle Surgery Smyrna, GA $132.22 1
, DPM Foot & Ankle Surgery Oakland, CA $132.22 1
, D.P.M Foot & Ankle Surgery Atlanta, GA $132.22 1
, DPM Podiatrist Naperville, IL $132.22 1
, DPM Podiatrist Philadelphia, PA $132.22 1
, DPM Foot & Ankle Surgery Sacramento, CA $132.22 1
, DPM Foot & Ankle Surgery Decatur, GA $132.22 1
, DPM Foot & Ankle Surgery Orlando, FL $132.22 1
, D.P.M Foot & Ankle Surgery Baton Rouge, LA $106.84 1
, DPM Foot & Ankle Surgery Cape Coral, FL $106.83 1
, DPM Podiatrist Oakwood, GA $106.83 1
, D.P.M Foot & Ankle Surgery Augusta, GA $106.83 1
, DPM Foot & Ankle Surgery Mountain View, CA $86.59 1
, MD Emergency Medicine Cumming, GA $68.45 1
, DPM Podiatrist Boardman, OH $48.16 1
, DPM Sports Medicine Norwood, OH $42.21 1

About DermaGide

DermaGide is a device associated with $749,359 in payments to 29 healthcare providers, recorded across 40 transactions in the CMS Open Payments database. The primary manufacturer is Geistlich Pharma, North America, Inc..

Payment data is available from 2019 to 2021. In 2021, $27,083 was paid across 38 transactions to 28 doctors.

The most common payment nature for DermaGide is "Unspecified" ($714,776, 95.4% of total).

DermaGide is associated with 1 research study, including "Retrospective Chart Review of Geistlich Derma Gide Wound Matrix in the Treatment of Diabetic Foot Ulcers" ($714,776).